Another study showed that reducing the release of calcitonin gene-related peptide from tumor-innervating nociceptors could be a strategy to alleviate this effect of nociceptors by improving anti-tumor immunity of cytotoxic CD8 + T cells in a melanoma model bearing mice (Balood et al., 2022). The gene discussed is CD8A; the disease is neoplasm.